Latent Autoimmune Diabetes in Adults (LADA)

被引:0
作者
Ramachandra G. Naik
Jerry P. Palmer
机构
[1] Bombay Hospital and Medical Research Center,
[2] University of Washington,undefined
来源
Reviews in Endocrine and Metabolic Disorders | 2003年 / 4卷
关键词
type 1 diabetes; type 2 diabetes; autoantibodies; late-onset type 1 diabetes; genetics; β-cell function;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:233 / 241
页数:8
相关论文
共 422 条
[61]  
Sundkvist G(1985)Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals Diabetologia 28 933-300
[62]  
Petersen JS(1992)Prevention of adoptive transfer in BB rats by prophylactic insulin treatment Diabetes 41 1273-937
[63]  
Boel E(1991)Insulin treatment prevents diabetes mellitus but not thyroiditis in RT6-depleted diabetes resistant BB/Wor rats Diabetologia 34 296-319
[64]  
Dyrberg T(1990)Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy Diabetes 39 933-634
[65]  
Lernmark A.(1991)Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse Diabetologia 34 314-554
[66]  
Tuomi T(1995)Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription J Clin Invest 95 628-36
[67]  
Groop LC(1989)A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus N Engl J Med 320 550-523
[68]  
Zimmet PZ(1987)Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: Observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT) J Clin Endocrinol Metab 65 30-626
[69]  
Rowley MJ(1998)Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial Ann Intern Med 128 517-130
[70]  
Knowles W(1996)Small doses of subcutaneous insulin as a strategy for preventing slowly progressive β-cell failure in islet cell antibody-positive patients with clinical features of NIDDM Diabetes 45 622-1691